Qventus
Last reviewed
Jun 8, 2026
Sources
10 citations
Review status
Source-backed
Revision
v1 · 1,574 words
Improve this article
Add missing citations, update stale details, or suggest a clearer explanation.
Suggest edit
CtrlK
Last reviewed
Jun 8, 2026
Sources
10 citations
Review status
Source-backed
Revision
v1 · 1,574 words
Add missing citations, update stale details, or suggest a clearer explanation.
Qventus is a privately held healthcare AI company that develops software to automate hospital and health system operations. Its platform applies machine learning, predictive analytics, and increasingly generative-AI agents to optimize patient flow, inpatient capacity, discharge planning, and perioperative or surgical scheduling, automating routine operational decisions to reduce delays and increase throughput.[1][2] The company is headquartered in Mountain View, California, and was founded in 2012 by Mudit Garg, who serves as chief executive officer, under the name AnalyticsMD before rebranding as Qventus in 2017.[3][4]
Qventus positions itself as a provider of "care operations automation" software rather than a clinical or diagnostic AI vendor. Its products sit on top of a health system's existing electronic health record, ingesting operational data to predict bottlenecks, such as a surgical block likely to go unused or a patient whose discharge is at risk of delay, and then prompting or directly executing the next best action. By 2025 the platform was in use at more than 115 hospitals and health systems in the United States, including academic medical centers and large multi-state systems.[1][5]
The company drew broad attention in January 2025 when it raised a $105 million Series D round led by the investment firm KKR, valuing Qventus at more than $400 million and roughly doubling its lifetime funding.[2][6] Qventus is frequently named among healthcare-technology companies considered candidates for an eventual initial public offering, alongside peers such as Innovaccer, Commure, and Hippocratic AI.[7]
Qventus was founded in 2012 as AnalyticsMD by Mudit Garg and co-founders, with the goal of bringing data science and automation to hospital operations, a domain that had historically relied on manual coordination, phone calls, and spreadsheets. Garg holds a master's degree in electrical engineering and an MBA from Stanford University, and before founding the company worked on lean process improvement and spent time in the healthcare practice of the consulting firm McKinsey & Company.[3][4]
The early product applied machine learning and other automation techniques to help hospital staff make better real-time operational decisions, initially focused on emergency-department and inpatient efficiency. On March 1, 2017, AnalyticsMD announced it had changed its name to Qventus, a name the company said reflected its broadening product line and the wider set of providers it served. Management framed the rebrand around the idea that emerging technology could "power the winds of change" in healthcare operations.[3][4]
Over the following years Qventus expanded from real-time decision support into a portfolio of operational solutions spanning inpatient capacity, perioperative or surgical growth, and command-center coordination, and it later incorporated generative AI into automated "assistants" that handle multi-step workflows. The company describes its trajectory as moving from analytics and alerts toward end-to-end automation of operational tasks.[1][8]
Qventus markets a small number of operational solutions built on a common AI platform, each targeting a different part of hospital throughput. The core offerings are summarized below.
| Solution | Operational focus | Representative outcomes claimed |
|---|---|---|
| Inpatient Capacity (Inpatient Flow) | Discharge planning, length-of-stay reduction, bed and capacity management | Reduction of excess patient days; the company reported eliminating more than 36,000 excess days across clients in 2024 [1][5] |
| Surgical Growth (Perioperative) | Operating-room scheduling, surgical block-time release and utilization | Release of unused block time and added surgical case volume; the company reported enabling roughly 14,000 additional surgeries in 2024 [5][8] |
| Command Center | Patient demand management, care progression, and post-acute placement coordination | System-wide operational visibility and automated patient placement [5] |
| AI Operational Assistants | Generative-AI agents that read, gather, and act on unstructured data across workflows | Automation of referrals, prior authorization, care-gap closure, and call workflows [1][8] |
The Inpatient Capacity solution automates discharge planning and capacity coordination to free up beds, while the Surgical Growth solution analyzes operating-room schedules to identify and release block time that would otherwise go unused, helping health systems perform more procedures with existing capacity.[5][8]
In 2024 and 2025, Qventus emphasized a newer layer of capability it calls AI Operational Assistants: generative-AI agents intended to act as automated teammates for overburdened administrative and clinical-support staff. The company describes these assistants as able to "speak, hear, read, gather, understand, and write," incorporating unstructured data to anticipate and execute next steps such as automating surgical prior authorization, orchestrating care-gap closure, optimizing site of care, and handling referral and call workflows.[1][8]
On September 18, 2025, at its inaugural client conference, QLive, Qventus introduced an "AI Solution Factory," a program that lets health systems co-develop new AI Operational Assistants for their own priority problems. The company said that across all clients in 2025 the platform powered roughly 135,000 block-release hours, influenced about 35,000 surgical cases, contributed to an average 13 percent increase in clients' robotic-surgery volume, and delivered an average annualized return on investment of about 10 times.[8] These figures are company-reported and have not been independently audited.
Qventus raised money across several rounds from venture and growth investors before its 2025 Series D. Reported earlier financing includes a $30 million Series B in 2018, with backing over time from Bessemer Venture Partners, the Mayfield Fund, and Norwest Venture Partners. In February 2022 the company announced a $50 million growth round led by Thomas H. Lee Partners (THL), together with a strategic partnership and investment from Premier, Inc., and participation from existing investors including Bessemer Venture Partners, Mayfield, and Norwest, plus the health system ThedaCare. That round brought lifetime funding to roughly $93 million.[9][10]
On January 13, 2025, announced during the J.P. Morgan Healthcare Conference, Qventus disclosed a $105 million Series D round led by KKR. According to reporting on the deal, the financing comprised approximately $85 million in equity plus about $20 million of optional debt, and valued the company at more than $400 million, up from a roughly $200 million valuation in 2022. The round brought Qventus's lifetime funding to approximately $200 million.[2][6] Participants alongside KKR included Bessemer Venture Partners and several strategic investor-customers: Northwestern Medicine, HonorHealth, and Allina Health.[2][6]
The exact valuation figure beyond "more than $400 million" was not disclosed by the company, and the split between equity and optional debt was reported by TechCrunch rather than stated in the company's own announcement.[2][6] At the time of the raise, management said the business was approaching break-even, citing roughly 120 percent net revenue retention and a customer base that had grown several-fold since 2022.[2]
The table below summarizes the principal disclosed rounds.
| Date | Round | Amount | Lead investor(s) |
|---|---|---|---|
| 2018 | Series B | $30 million | Norwest, Mayfield, Bessemer (reported) [9] |
| February 2022 | Growth | $50 million | Thomas H. Lee Partners; Premier, Inc. [9][10] |
| January 2025 | Series D | $105 million ($85M equity + ~$20M optional debt) | KKR [2][6] |
Qventus operates in the market for hospital operations and capacity-management software, a segment of healthcare AI focused on administrative and logistical efficiency rather than diagnosis or treatment. Demand in this area has been driven by persistent hospital staffing shortages, financial pressure on health systems, and chronic capacity constraints that lengthen patient stays and leave operating rooms underused.[1][7]
Its most frequently cited direct competitor is LeanTaaS, which likewise uses predictive analytics and machine learning to optimize operating rooms, infusion centers, and inpatient flow. Other companies cited in the competitive landscape include Commure, which builds software for care delivery and hospital operations; TeleTracking Technologies, a longstanding vendor of patient-flow and capacity-management systems; and Hippocratic AI, a startup building generative-AI agents for healthcare. Qventus is also frequently compared with broader health-data platforms such as Innovaccer, and it must coexist with the dominant electronic-health-record vendor Epic Systems, whose own scheduling and capacity tools both compete with and integrate alongside third-party operations software.[5][7]
Analysts and trade press have grouped Qventus with a cohort of healthcare-technology companies viewed as potential public-offering candidates for 2026, reflecting investor interest in applying AI to the operational and administrative side of healthcare. The company's significance lies in being one of the most prominent vendors demonstrating that machine learning and, increasingly, generative-AI agents can automate hospital operational decisions at scale, an area distinct from the clinical and diagnostic applications that attract much of the attention in healthcare AI.[1][7]